GEN Exclusives

More »

GEN News Highlights

More »
May 18, 2009

AbD Serotec and BBInternational Ink Reciprocal Marketing Agreement

  • AbD Serotec , the research and diagnostics antibody division of MorphoSys , and BBInternational  signed an agreement to comarket each other’s products and services worldwide.

    The agreement will give BBI’s customers access to over 13,000 antibodies and immunological reagents and custom monoclonal antibodies developed from the MorphoSys HuCAL library, along with AbD Serotec’s large- and small-scale antibody production and conjugation services.

    AbD Serotec will in turn have direct access to BBI’s complementary range of services for the production of gold-labeled reagents, contract research and development, and manufacture of rapid diagnostic tests for point of care markets.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?